We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Spire Healthcare Group Plc | LSE:SPI | London | Ordinary Share | GB00BNLPYF73 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.50 | 0.20% | 247.00 | 247.00 | 247.50 | 248.00 | 246.50 | 248.00 | 229,153 | 14:32:41 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Health & Allied Services,nec | 1.36B | 27.3M | 0.0676 | 36.46 | 996.18M |
Date | Subject | Author | Discuss |
---|---|---|---|
07/3/2022 14:18 | Director buys and Tosca fund adding last Friday. From memory, Tosca were one of the shareholders who rejected the takeover last year. | mongrels3 | |
04/3/2022 08:09 | Me too early yesterday morning | gswredland | |
03/3/2022 17:21 | Same here. | montyhedge | |
03/3/2022 16:30 | Disappointing so I'm out | dekle | |
03/3/2022 16:11 | No dividend disappointed me. | montyhedge | |
02/3/2022 14:40 | All this trouble in the world markets, good to stick with U.K. based businesses. | montyhedge | |
23/2/2022 14:50 | £3.00 minimum | dekle | |
17/2/2022 15:46 | No strange. Just bought in | gswredland | |
17/2/2022 15:31 | Interesting drop? Can't see any news. | richtea2517 | |
11/2/2022 16:21 | Can’t wait for these figures. | montyhedge | |
01/2/2022 14:45 | Figures few weeks time, I'm looking for record profits. | montyhedge | |
16/1/2022 21:42 | Simply Wall Street data saying fair value 465p. No wonder the bid was rejected at 250p. | montyhedge | |
11/1/2022 08:44 | Historically p.e 33, self funding healthcare is booming, I reckon 6 out of 10, who use Spire paying with credit card, the rest private insurance. If you’re in pain or waiting for a consultation you will pay for a quicker outcome. Someone will have another go at bidding for this company. This time they would have to pay 375p, I can’t see hedgies selling out any cheaper. NHS using Spire again for elective surgery a bonus. | montyhedge | |
10/1/2022 21:02 | Monty. It's a good bull case article but 33x rating doesn't lead any room for missteps. I do believe £3 is possible by end of 2022 and have been consistent on this point but holding out for £4 feels a bit rich. | fozzyb | |
10/1/2022 14:20 | https://www.fool.co. | montyhedge | |
10/1/2022 14:18 | These will be bid for, hedgies would not sell out below 400p.I'm watching any stake building. No doubt there is a boom in self funding if no private insurance, rather than wait months or years for NHS. | montyhedge | |
22/12/2021 19:16 | Good to see they are investing in the hospital business and divesting from the property business at a time when we need more hospital capacity | dekle | |
03/12/2021 09:50 | Analyst Recommendation: BARCLAYS RAISES SPIRE HEALTHCARE PRICE TARGET TO 300 (280) PENCE - 'OVERWEIGHT' | mongrels3 | |
15/10/2021 07:46 | Mediclinic reported a 12% rise in revenue for the first half, while group EBITDA margins recovered to 15.5% from 12.1% a year ago | mongrels3 | |
30/9/2021 20:08 | Hoping it's a classic tree shake And anticipating strong rebound | richtea2517 | |
30/9/2021 10:59 | I can’t disagree with that, Richtea2517, it looks a good level to get in and I’m sure you’ll do ok. There has only been one day, 19/7, when the price has been lower, since the bid news broke in May. I actually sold out just after the bid was announced, but have been looking to get back in around this level. Rightly or wrongly, given the recent weakness, I’m still watching to see if we keep going off to touch the pre-bid levels gap of 193p. Good luck everyone, Sid. | eaaxs06 | |
30/9/2021 10:19 | Had a nibble at this price | richtea2517 | |
10/9/2021 07:49 | In my IG Morning Call email this morning: Spire Healthcare raised to overweight at Barclays | mongrels3 | |
07/9/2021 07:22 | hxxps://www.msn.com/ | mongrels3 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions